Stockreport

Intellipharmaceutics Announces Start of Intranasal Human Abuse Liability Studies for Oxycodone ER

INTELLIPHARMACEUTICS  (IPCI) 
Last intellipharmaceutics earnings: 10/15 05:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.intellipharmaceutics.com